UNSPSC 51262904: Mepindolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00Q31ER368. European Medicines Agency schedules Mepindolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08750MIG. Mepindolol generally arises in the molecular formula C15H22N2O2.

UNSPSC 51262904 Mepindolol is a Commodity code, but the recent state and local opportunities tagged under it do not reflect mepindolol procurement — instead they represent naloxone acquisition and prescription pharmacy management services. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB (Solicitation Number IFB60459723LAS, due July 26, 2023), while the Texas Health and Human Services Commission issued an RFI to explore direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager channels. The mismatch between the code's nominal scope and actual procurement activity suggests this code sees limited relevant state and local activity in the tracked opportunities. Where activity does appear, it centers on public health agencies and state health authorities procuring opioid-response and pharmacy benefit management services rather than mepindolol as a standalone pharmaceutical input.

Geographically, the recent opportunities span Florida and Texas. Seminole County's naloxone procurement required quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping costs and subject to two-year terms with one-year renewal options, drug-free workplace certification, and E-Verify compliance. The Texas HHS Commission's RFI, posted April 3, 2026, functioned as exploratory market research ahead of formal competitive solicitation, seeking vendor capacity to negotiate direct manufacturer contracts with self-insured employers and state employee plans without traditional pharmacy benefit manager intermediation. Neither opportunity explicitly designated set-asides for disadvantaged enterprises, though the Seminole County IFB included potential FEMA funding with attendant federal compliance requirements.